🔥🐔 BizChicken 🐔🔥
Companies Similar to Keros Therapeutics, Inc.
Sign Up Today!
Sign up for BizChicken and discover more about the corporations around you.
Candel Therapeutics, Inc.
CAN-2409, CAN-3110
Candel Therapeutics, Inc. is a clinical stage biopharmaceutical company focused on developing immunotherapies for cancer patients, with products like CAN-2409 and CAN-3110 in various clinical trial phases.
About | About | About | About | Contact | Careers | Careers | About | About | About | Careers | About
Symbol: CADL
Recent Price: $7.95
Industry: Biotechnology
CEO: Dr. Paul-Peter Tak FOCIS, M.D., Ph.D.
Sector: Healthcare
Employees: 42
Address: 117 Kendrick Street, Needham, MA 02494
Phone: 617 916 5445
Last updated: 2024-12-31
CERo Therapeutics Holdings, Inc.
Engineered T Cell Therapeutics
CERo Therapeutics Holdings, Inc. is an immunotherapy company focused on developing engineered T cell therapeutics for cancer treatment, particularly targeting hematologic malignancies using innovative immune system integration strategies.
Symbol: CERO
Recent Price: $0.06
Industry: Biotechnology
CEO: Mr. Christopher B. Ehrlich M.B.A.
Sector: Healthcare
Employees: 8
Address: 201 Haskins Way, South San Francisco, CA 94080
Phone: 650-407-2376
Last updated: 2024-12-31
Elicio Therapeutics, Inc.
ELI-002
Elicio Therapeutics is a clinical-stage biotechnology company developing a pipeline of novel immunotherapies for cancer and other diseases, with its lead product ELI-002 targeting KRAS-driven cancers.
Symbol: ELTX
Recent Price: $5.00
Industry: Biotechnology
CEO: Mr. Robert T. Connelly
Sector: Healthcare
Employees: 32
Address: 451 D Street, Boston, MA 02210
Phone: 857-209-0050
Last updated: 2024-12-31
Kiromic BioPharma, Inc.
ALEXIS-ISO-1, ALEXIS-PRO-1
Kiromic Bio Pharma, Inc. is an artificial intelligence-driven allogeneic cell therapy company that develops multi-indication T cell therapies, leveraging the Gamma Delta T cell to target solid tumors. Key products include ALEXIS-ISO-1 and ALEXIS-PRO-1.
Symbol: KRBP
Recent Price: $0.93
Industry: Biotechnology
CEO: Mr. Pietro Bersani CPA, J.D.
Sector: Healthcare
Employees: 35
Address: 7707 Fannin, Houston, TX 77054
Phone: 832 968 4888
Leadership
- Pietro Bersani, CPA, Director
- Leonardo Mirandola, PhD, Chief Scientific Officer/Interim COO
- Scott Dahlbeck, MD, PharmD, Chief of Staff
- Brian Hungerford, Chief Financial Officer
- Michael Nagel, Chairperson
- Michael Catlin, Independent Director
- Pam Misajon, Independent Director
Last updated: 2024-12-31
Pyxis Oncology, Inc.
PYX-106, PYX-102, PYX-201, PYX-202, PYX-203
Pyxis Oncology, Inc., a preclinical stage biopharmaceutical company, focuses on developing therapies to treat various cancers through immune-oncology and antibody drug conjugate product candidates.
Symbol: PYXS
Recent Price: $1.56
Industry: Biotechnology
CEO: Dr. Lara S. Sullivan M.D., MBA
Sector: Healthcare
Employees: 55
Address: 35 Cambridgepark Drive, Cambridge, MA 02140
Phone: 617 221 9059
Last updated: 2024-12-31
Astria Therapeutics, Inc.
STAR-0215
Astria Therapeutics, Inc., is a biopharmaceutical company that focuses on the discovery, development, and commercialization of therapeutics for rare and niche allergic and immunological diseases in the United States. Its lead product candidate, STAR-0215, is targeting hereditary angioedema.
Symbol: ATXS
Recent Price: $8.88
Industry: Biotechnology
CEO: Ms. Jill C. Milne Ph.D.
Sector: Healthcare
Employees: 59
Address: 100 High Street, Boston, MA 02110
Phone: 617 349 1971
Last updated: 2024-12-31
Axsome Therapeutics, Inc.
AXS-05, AXS-07, AXS-12, AXS-14
Axsome Therapeutics, Inc. is a biopharmaceutical company focused on developing novel therapies for central nervous system disorders such as major depressive disorder, migraine, narcolepsy, and fibromyalgia.
About | Leadership | Directors | About | About | About | About | About | About | Contact | Careers | Careers | About | About
Symbol: AXSM
Recent Price: $84.78
Industry: Biotechnology
CEO: Dr. Herriot Tabuteau M.D.
Sector: Healthcare
Employees: 589
Address: 22 Cortlandt Street, New York, NY 10007
Phone: 212 332 3241
Leadership
- Herriot Tabuteau, MD, CHIEF EXECUTIVE OFFICER
- Nick Pizzie, CPA, MBA, CHIEF FINANCIAL OFFICER
- Mark Jacobson, MA, CHIEF OPERATING OFFICER
- Hunter Murdock, Esq., GENERAL COUNSEL
- ari Maizel, Executive Vice President, Head of Commercial
- Mark Coleman, MD, DIRECTOR
- Roger Jeffs, PhD, DIRECTOR
- Susan Mahony, PhD, MBA, DIRECTOR
- Mark Saad, DIRECTOR
Last updated: 2024-12-31
Hoth Therapeutics, Inc.
Various Therapeutic Treatments
Hoth Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing therapies for unmet medical needs, including treatments for skin disorders, cancers, neuroinflammatory diseases, and more.
Symbol: HOTH
Recent Price: $0.76
Industry: Biotechnology
CEO: Mr. Robb Knie
Sector: Healthcare
Employees: 2
Address: 1 Rockefeller Plaza, New York, NY 10020
Phone: 646 756 2997
Leadership
- Robb Knie, Founder, President, and Chief Executive Officer
- David Briones, Chief Financial Officer
- Hayley Springer, Executive Vice President Operations
Last updated: 2024-12-31
Jasper Therapeutics, Inc.
JSP191
Jasper Therapeutics, Inc. is a clinical-stage biotechnology company developing therapeutic agents for hematopoietic stem cell transplantation and gene therapies. Its lead product candidate JSP191 is in clinical development for clearing hematopoietic stem cells from bone marrow in patients prior to transplantation.
Symbol: JSPR
Recent Price: $20.95
Industry: Biotechnology
CEO: Mr. Ronald A. Martell
Sector: Healthcare
Employees: 45
Address: 2200 Bridge Pkwy, Redwood City, CA 94065
Phone: 650 549 1400
Last updated: 2024-12-31
Kiora Pharmaceuticals, Inc.
KIO-301
Kiora Pharmaceuticals, Inc. develops therapies for ophthalmic diseases, with lead product KIO-301 in Phase 1 trial for vision restoration in degenerative retinal diseases and other products in trials for conditions like rheumatoid arthritis-related ocular issues and corneal wound repair.
Symbol: KPRX
Recent Price: $3.30
Industry: Biotechnology
CEO: Dr. Brian M. Strem Ph.D.
Sector: Healthcare
Employees: 12
Address: 1371 East 2100 South, Salt Lake City, UT 84105
Phone: 781 788 8869
Last updated: 2024-12-31
Keros Therapeutics, Inc.
KER-050
Keros Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing treatments for hematological and musculoskeletal disorders. Their lead product candidate, KER-050, targets cytopenias, including anemia and thrombocytopenia.
About | Management | Directors | Contact | About | Contact | Careers | Benefits | Careers | About | Benefits | About | Careers | Jobs | Careers | Careers | Careers
Symbol: KROS
Recent Price: $15.64
Industry: Biotechnology
CEO: Dr. Jasbir S. Seehra Ph.D.
Sector: Healthcare
Employees: 149
Address: 99 Hayden Avenue, Lexington, MA 02421
Phone: 617 314 6297
Leadership
- Jasbir Seehra, Ph.D., Board Member
- Keith Regnante, M.B.A., Chief Financial Officer
- Christopher Rovaldi, President, Chief Operating Officer
- Esther Cho, J.D., Senior Vice President, General Counsel
- John Oram, M.B.A., Senior Vice President, Program and Portfolio Management
- Robin Wagner, Senior Vice President, Human Resources
- Carl L. Gordon, Ph.D., C.F.A., Board Member
- Jean-Jacques Bienaimé, M.B.A., Lead Independent Director
- Nima Farzan, M.B.A., Board Member
- Mary Ann Gray, Ph.D., Board Member
- Tomer Kariv, J.D., Board Member
- Julius Knowles, M.B.A., Board Member
- Ran Nussbaum, Board Member
- Alpna Seth, Ph.D., Board Member
Last updated: 2024-12-31
Kintara Therapeutics, Inc.
VAL-083, REM-001
Kintara Therapeutics is a clinical stage drug development company focused on developing and commercializing anti-cancer therapies for drug-resistant solid tumors.
About | Leadership | Directors | About | About | About | About | Contact | Careers | About | About | About
Symbol: KTRA
Recent Price: $0.22
Industry: Biotechnology
CEO: Mr. Jeffrey A. Bacha B.Sc., M.B.A.
Sector: Healthcare
Employees: 1
Address: 12707 High Bluff Drive, San Diego, CA 92130
Phone: 858 350 4364
Leadership
- Robert E. Hoffman, President, CEO, CFO and Chairman of the Board
- Greg A. Johnson, (Acting) Head of Operations
- Laura Johnson, Director
- Tamara A. Favorito, Director
- Robert J. Toth, Jr., M.B.A., Director
Last updated: 2024-12-31
Kura Oncology, Inc.
ziftomenib and tipifarnib
Kura Oncology, Inc. is a clinical-stage biopharmaceutical company developing small molecule medicines for the treatment of cancer. It focuses on genetically defined subsets of acute leukemias and has a collaboration with Novartis for certain carcinoma treatments.
Symbol: KURA
Recent Price: $8.51
Industry: Biotechnology
CEO: Dr. Troy Edward Wilson J.D., Ph.D.
Sector: Healthcare
Employees: 142
Address: 12730 High Bluff Drive, San Diego, CA 92130
Phone: 858 500 8800
Last updated: 2024-12-31
Kymera Therapeutics, Inc.
novel small molecule therapeutics
Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system.
About | About | Leadership | Foundation | Contact | Culture | About | About | Leadership | Foundation | About | About | About | Culture | Culture | Culture | Culture | About | About
Symbol: KYMR
Recent Price: $39.32
Industry: Biotechnology
CEO: Dr. Nello Mainolfi M.D., Ph.D.
Sector: Healthcare
Employees: 184
Address: 200 Arsenal Yards Boulevard, Watertown, MA 02472
Phone: 857 285 5300
Leadership
- Nello Mainolfi, Ph.D., Founder, President & CEO
- Jeremy Chadwick, Ph.D., Chief Operating Officer
- Ellen Chiniara, JD, Chief Legal Officer and Corporate Secretary
- Jared Gollob, MD, Chief Medical Officer
- Bruce Jacobs, CFA, MBA, Chief Financial Officer
- Karen Weisbach, Head of People and Culture
- Juliet Williams, Ph.D., Head of Research
- Bruce Booth, DPhil, Chairman and Co-Founder
- Felix J. Baker, PhD, Lead Independent Director
- Jeff Albers, JD, MBA,
- Pamela Esposito, PhD,
- Gorjan Hrustanovic, PhD,
- John Maraganore, PhD,
- Leigh Morgan,
- Victor Sandor, MDCM,
- Elena Ridloff, CFA,
Last updated: 2024-12-31
Kezar Life Sciences, Inc.
KZR-616
Kezar Life Sciences is a clinical-stage biotechnology company focused on developing novel small molecule therapeutics to address unmet needs in immune-mediated diseases and cancer in the United States.
About | About | About | About | Directors | About | Contact | Contact | Careers | Careers | Careers | Leadership | About | About | About | About | About | About | About | News | About | Careers | Contact | Careers | Careers | Careers | About | About | About | About
Symbol: KZR
Recent Price: $6.82
Industry: Biotechnology
CEO: Dr. Christopher J. Kirk Ph.D.
Sector: Healthcare
Employees: 58
Address: 4000 Shoreline Court, South San Francisco, CA 94080
Phone: 650 822 5600
Leadership
- Christopher Kirk, PhD, Chief Executive Officer, Co-Founder
- Marc Belsky, Chief Financial Officer
- Mark Schiller, Chief Legal Officer
- Neel K. Anand, DPhil, SVP, Research and Drug Discovery
- Zung To, SVP, Clinical Development
- Gitanjali Jain, SVP, Investor Relations and External Affairs
- Michelle Greenman, VP, Global Regulatory Affairs
- Jim Kirchner, PhD, VP, CMC and Supply Chain
- Andrew Basham, VP, Legal Affairs
- Dave Braggs, VP, Quality Assurance
- Pattie Chiang, SVP, Corporate Controller
- Tony Muchamuel, VP, Pharmacology & Toxicology
- Kiruthi Palaniswamy, PharmD, VP, Medical Affairs
- Mary Rogers, VP, Financial Planning & Analysis
- Joe Tedrick, VP, Human Resources
- Jinhai Wang, PhD, VP, Drug Metabolism & Pharmacokinetics
- John Fowler, Co-Founder
- Graham Cooper, Board Member, Beam Therapeutics, Former CFO, Receptos
- Franklin Berger, Founder
- Elizabeth Garner, MD, MPH, Chief Science Officer
- Michael Kauffman, MD, PhD, President, Chief Executive Officer, and Director
- Micki Klearman, MD, Former Group Medical Director
- Courtney Wallace, Venture Partner
Last updated: 2024-12-31
Nkarta, Inc.
NKX101 and NKX019
Nkarta, Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing cell therapies for the treatment of cancer. The company specializes in cellular immunotherapy using chimeric antigen receptors on natural killer cells to target tumor antigens.
About | Contact | Careers | Careers | Careers | Jobs | Careers | Careers | Careers | Careers | Careers | Careers | Contact | Careers | About | Careers
Symbol: NKTX
Recent Price: $2.32
Industry: Biotechnology
CEO: Mr. Paul J. Hastings
Sector: Healthcare
Employees: 150
Address: 6000 Shoreline Court, South San Francisco, CA 94080
Phone: 415 582 4923
Last updated: 2024-12-31
Poseida Therapeutics, Inc.
P-PSMA-101
Poseida Therapeutics, Inc. is a clinical-stage biopharmaceutical company focusing on developing innovative CAR-T therapies for patients with high unmet medical needs, including treatments for prostate cancer, multiple myeloma, and various solid tumors.
Symbol: PSTX
Recent Price: $9.48
Industry: Biotechnology
CEO: Dr. Kristin Yarema Ph.D.
Sector: Healthcare
Employees: 337
Address: 9390 Towne Centre Drive, San Diego, CA 92121
Phone: 858 779 3100
Last updated: 2024-12-31
Protara Therapeutics, Inc.
N/A
Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the identifying and advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy for the treatment of lymphatic malformations. It also develops intravenous choline chloride, an investigational phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease. The company was formerly known as ArTara Therapeutics, Inc. and changed its name to Protara Therapeutics, Inc. in May 2020. Protara Therapeutics, Inc. is headquartered in New York, New York.
No tags available.
Symbol: TARA
Recent Price: $5.28
Industry: Biotechnology
CEO: Mr. Jesse Shefferman
Sector: Healthcare
Employees: 26
Address: 345 Park Avenue South, New York, NY 10010
Phone: 646 844 0337
Last updated: 2024-12-31
Verve Therapeutics, Inc.
VERVE-101
Verve Therapeutics, Inc. is a genetic medicines company developing gene editing treatments for cardiovascular diseases, primarily through its lead product VERVE-101.
Symbol: VERV
Recent Price: $5.54
Industry: Biotechnology
CEO: Dr. Sekar Kathiresan M.D.
Sector: Healthcare
Employees: 255
Address: 500 Technology Square, Cambridge, MA 02139
Phone: 617 603 0070
Leadership
- Andrew Ashe, President, Chief Operating Officer and General Counsel
- Victoria Bartlett, Vice President, Program and Alliance Management
- Dan Balian, Associate Director, Supply Chain Management
- Allen Barrett, Director, Corporate Counsel
Last updated: 2024-12-31
Seelos Therapeutics, Inc.
SLS-002, SLS-005, SLS-006, SLS-007, SLS-008, SLS-004, SLS-010
Seelos Therapeutics, Inc. is focused on developing and commercializing therapeutics for central nervous system, respiratory, and other disorders, with lead programs targeting major depressive disorders, amyotrophic lateral sclerosis, Sanfilippo syndrome, and Parkinson's disease.
Symbol: SEEL
Recent Price: $0.37
Industry: Biotechnology
CEO: Dr. Raj Mehra J.D., Ph.D.
Sector: Healthcare
Employees: 8
Address: 300 Park Avenue, New York, NY 10022
Phone: 646 293 2100
Last updated: 2024-12-31